A carregar...
Biosimilars 101: considerations for U.S. oncologists in clinical practice
Biosimilars of biologics used for cancer treatment and supportive care are expected to enter the U.S. market soon. Biosimilars will be highly similar to their reference products, but unlike generic drugs, not identical. Differences between a biosimilar and its reference product may arise because of...
Na minha lista:
| Publicado no: | Cancer Med |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BlackWell Publishing Ltd
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4303156/ https://ncbi.nlm.nih.gov/pubmed/24810680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.258 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|